BioMarin Pharmaceutical Inc. (OQ:BMRN)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 12/20 May 8/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -20,000  
May 12/20 May 8/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -20,000 $91.72
May 12/20 May 8/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $21.51
May 6/20 May 4/20 Guyer Charles Greg Direct Ownership Stock Option (Right to buy Common Stock) A - Grant, award or other under Rule 16b-3(d) 64,150  
May 6/20 May 4/20 Guyer Charles Greg Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 35,040  
May 5/20 May 4/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -5,000  
May 5/20 May 4/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -5,000 $88.00
May 5/20 May 4/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $21.51
May 5/20 May 1/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
May 5/20 May 1/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $89.38
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 12/20 May 8/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -20,000  
May 12/20 May 8/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -20,000 $91.72
May 12/20 May 8/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $21.51
May 6/20 May 4/20 Guyer Charles Greg Direct Ownership Stock Option (Right to buy Common Stock) A - Grant, award or other under Rule 16b-3(d) 64,150  
May 6/20 May 4/20 Guyer Charles Greg Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 35,040  
May 5/20 May 4/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -5,000  
May 5/20 May 1/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
May 5/20 May 4/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -5,000 $88.00
May 5/20 May 4/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $21.51
May 5/20 May 1/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $89.38
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BMRN

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Allakos (OQ:ALLK)
Apellis Pharmaceuticals (OQ:APLS)